Back to search

United States· US:76281-601_e2f34ff2-7880-4bdf-9193-5873515400f3

Maximum Strength Tussin DM Liquid filled Softgels

A medicinal product containing dextromethorphan hydrobromide; guaifenesin, registered in United States by AptaPharma Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMaximum Strength Tussin DM Liquid fil…ATC—REGISTER NO.US:76281-601_e2f34ff2…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Manufacturer
AptaPharma Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7628160102
    2 BLISTER PACK in 1 CARTON (76281-601-02) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
  • ndc11
    76281-601-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dextromethorphan hydrobromide; guaifenesin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dextromethorphan hydrobromide; guaifenesin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Spain · Broncomedical Con Guaifenesina, Cinfatós Expectorante
  • Italy · Bronchenolo Sedativo E Fluidificante, Bronchenolo Sedativo E Fluidificante Gusto Menta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fef7cf20-62f7-46af-aab4-ca13d337a339
GET /v1/drugs/fef7cf20-62f7-46af-aab4-ca13d337a339?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10; 200",
  "substance": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
  "productndc": "76281-601",
  "dosage_form": "CAPSULE, LIQUID FILLED",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "M012",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about dextromethorphan hydrobromide; guaifenesin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.